Food-derived peptides with inhibitory capacity for HMG-CoA reductase activity: a potential nutraceutical for hypercholesterolemia
Cardiovascular diseases (CVDs) are the leading global cause of mortality and disease burden. Statins are the most prescribed lipid-lowering drugs to treat hypercholesterolemia and prevent CVDs. The biochemical mechanism of statins consists of competitive inhibition of the 3-hydroxy-3-methylglutaryl-...
Saved in:
Main Authors: | Guillermo Santos-Sánchez, Ana Isabel Álvarez-López, Eduardo Ponce-España, Patricia Judith Lardone, Antonio Carrillo-Vico, Ivan Cruz-Chamorro |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2024-11-01
|
Series: | Food Science and Human Wellness |
Subjects: | |
Online Access: | https://www.sciopen.com/article/10.26599/FSHW.2023.9250001 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis
by: Hamdy A. Makhlouf, et al.
Published: (2025-02-01) -
HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
by: Xuemei Li, et al.
Published: (2013-01-01) -
Familial Hypercholesterolemia: Genetics, Symptoms, Diagnosis and Treatment - A Literature Overview
by: Maciej Rutkiewicz, et al.
Published: (2025-02-01) -
An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01) -
Hypolipidemic Effect of Chloroform Extract of Lagenaria siceraria: Potential Inhibitory Activity of Phytochemicals Targeting the HMG-CoA Reductase Revealed by Molecular Docking and Simulation Studies
by: Qudsia Kanwal, et al.
Published: (2023-01-01)